These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

670 related items for PubMed ID: 10595477

  • 21. Technetium-99m tetrofosmin parathyroid imaging in patients with primary hyperparathyroidism.
    Hiromatsu Y, Ishibashi M, Nishida H, Okuda S, Miyake I.
    Intern Med; 2000 Feb; 39(2):101-6. PubMed ID: 10732824
    [Abstract] [Full Text] [Related]

  • 22. Kinetics of Tc-99m sestamibi and Tc-99m tetrofosmin in a case of parathyroid adenoma.
    Mansi L, Rambaldi PF, Marino G, Pecori B, Del Vecchio E.
    Clin Nucl Med; 1996 Sep; 21(9):700-3. PubMed ID: 8879870
    [Abstract] [Full Text] [Related]

  • 23. Limited sensitivity of parathyroid imaging with (99m)Tc-sestamibi/(123)I subtraction in an endemic goiter area.
    Rink T, Schroth HJ, Holle LH, Garth H.
    J Nucl Med; 2002 Sep; 43(9):1175-80. PubMed ID: 12215555
    [Abstract] [Full Text] [Related]

  • 24. Tc-99m sestamibi parathyroid gland scintigraphy: added value of Tc-99m pertechnetate thyroid imaging for increasing interpretation confidence and avoiding additional testing.
    Powell DK, Nwoke F, Goldfarb RC, Ongseng F.
    Clin Imaging; 2013 Sep; 37(3):475-9. PubMed ID: 23102932
    [Abstract] [Full Text] [Related]

  • 25. Technetium-99m-sestamibi/thallium-201 mismatch of thyroid and parathyroid adenoma in chronic renal failure.
    Pijpers R, van Loon BJ, Roos JC, Hoekstra OS.
    J Nucl Med; 1995 May; 36(5):826-8. PubMed ID: 7738659
    [Abstract] [Full Text] [Related]

  • 26. Differences between 99mTc-sestamibi and 99mTc-tetrofosmin uptake in thyroid and salivary glands: comparison with 99mTc-pertechnetate in 86 subjects.
    Giordano A, Meduri G, Marozzi P, Rubini G, Burroni L, Cappagli M.
    Nucl Med Commun; 2003 Mar; 24(3):321-6. PubMed ID: 12612474
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Impaired Tc-99m MIBI uptake in the thyroid and parathyroid glands during early phase imaging in hemodialysis patients.
    Kiratli PO, Ceylan E, Naldöken S, Beylergil V.
    Rev Esp Med Nucl; 2004 Mar; 23(5):347-51. PubMed ID: 15450141
    [Abstract] [Full Text] [Related]

  • 29. Preoperative parathyroid gland localization with technetium-99m sestamibi in secondary hyperparathyroidism.
    Pons F, Torregrosa JV, Vidal-Sicart S, Sabater L, Fuster D, Fernández-Cruz L, Herranz R.
    Eur J Nucl Med; 1997 Dec; 24(12):1494-8. PubMed ID: 9391184
    [Abstract] [Full Text] [Related]

  • 30. [Various dynamics of Tc-99m-tetrofosmin and Tc-99m-MIBI in a parathyroid adenoma].
    Nowak B, Sabri O, Hoff C, Reinartz P, Kleinhans E, Zimny M.
    Nuklearmedizin; 1999 Dec; 38(5):160-3. PubMed ID: 10488484
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Technetium-99m methoxy isobutyl isonitrile (MIBI) imaging of the parathyroid glands in patients with renal failure.
    Chesser AM, Carroll MC, Lightowler C, Macdougall IC, Britton KE, Baker LR.
    Nephrol Dial Transplant; 1997 Jan; 12(1):97-100. PubMed ID: 9027781
    [Abstract] [Full Text] [Related]

  • 33. Thallium-technetium-subtraction scintigraphy in secondary hyperparathyroidism.
    Adalet I, Hawkins T, Clark F, Wilkinson R.
    Eur J Nucl Med; 1994 Jun; 21(6):509-13. PubMed ID: 8082665
    [Abstract] [Full Text] [Related]

  • 34. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout.
    Leslie WD, Dupont JO, Bybel B, Riese KT.
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1566-70. PubMed ID: 12458389
    [Abstract] [Full Text] [Related]

  • 35. Parathyroid glands: combination of sestamibi-(99m)Tc scintigraphy and ultrasonography for demonstration of hyperplasic parathyroid glands.
    Kasai ET, da Silva JW, Mandarim de Lacerda CA, Boasquevisque E.
    Rev Esp Med Nucl; 2008 Dec; 27(1):8-12. PubMed ID: 18208776
    [Abstract] [Full Text] [Related]

  • 36. Tc-99m tetrofosmin. A new diagnostic tracer for parathyroid imaging.
    Ishibashi M, Nishida H, Kumabe T, Morita S, Matoba F, Nomura G, Hayabuchi N.
    Clin Nucl Med; 1995 Oct; 20(10):902-5. PubMed ID: 8616997
    [Abstract] [Full Text] [Related]

  • 37. Technetium-99m tetrofosmin imaging in thyroid diseases: comparison with Tc-99m-pertechnetate, thallium-201 and Tc-99m-methoxyisobutylisonitrile scans.
    Klain M, Maurea S, Cuocolo A, Colao A, Marzano L, Lombardi G, Salvatore M.
    Eur J Nucl Med; 1996 Dec; 23(12):1568-74. PubMed ID: 8929309
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Impact of technetium-99m-sestamibi localization on operative time and success of operations for primary hyperparathyroidism.
    Casas AT, Burke GJ, Mansberger AR, Wei JP.
    Am Surg; 1994 Jan; 60(1):12-6; discussion 16-7. PubMed ID: 8273968
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.